| Professional Services Industry | Industrials Sector | Mr. Hongwei Yang CEO | XSHE Exchange | CNE100005CP8 ISIN |
| China Country | 4,271 Employees | - Last Dividend | 6 Jun 2024 Last Split | - IPO Date |
SMO ClinPlus CO., LTD., founded in 2009 and headquartered in Shanghai, China, specializes in providing comprehensive site management organization (SMO) services. These services play a crucial role in facilitating research development in the fields of pharmaceuticals, medical devices, and health-related products within China. The company aims to streamline and enhance the efficiency of clinical trials, which is fundamental for the successful development and approval of new medical treatments and innovations.
SMO ClinPlus CO., LTD. offers a diversified portfolio of SMO services tailored to meet the complex demands of clinical trials, including:
- This service involves the creation of theoretical models based on the clinical trial's objectives and requirements. It lays the groundwork for designing effective and efficient study protocols.
- Essential for the initial stages of clinical research, this service encompasses the formulation of detailed plans, ensuring that all aspects of the trial, including logistics, regulatory compliance, and timelines, are thoroughly addressed.
- Focused on setting up and preparing clinical trial sites for operation, this service includes the recruitment of sites, training of site staff, and ensuring all necessary infrastructure and resources are in place.
- Once the trial is underway, SMO ClinPlus provides on-the-ground support to manage day-to-day operations. This ensures that the trial is conducted according to plan, with adherence to regulatory standards and protocols.
- Comprehensive project management services are offered to oversee the entire lifecycle of the clinical trial. This includes monitoring progress, managing communications between stakeholders, and ensuring milestones are met on time and within budget.